Rapamycin analog as immunosuppressant
US5202332A · kind A · utility
39Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 1992 |
| Grant date | Apr 13, 1993 |
| Priority date | — |
| Expiry date | Aug 5, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/01
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Reduction of the C-33 ketone of rapamycin gives the C-33 hydroxy analog of Formula I. ##STR1## The reduction product prevents cleavage of the C-31/C-32 bond due to base degradation. The Formula I compounds exhibit immunosuppressant, antifungal, and antiinflammatory activities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.